Medication for opioid use disorder is essential for reducing overdose deaths and supporting recovery in correctional settings. Yet jails face persistent barriers such as diversion, staffing shortages, and limited funding. Comparing oral and long-acting buprenorphine formulations reveals powerful lessons on how to balance patient-centered care with operational realities. This lightning talk reviews Norfolk City Jail'ss rollout of oral Suboxone versus long-acting buprenorphine injections and offers a roadmap for correctional facilities seeking to align clinical best practices with operational feasibility.

Educational Objectives

• Describe the clinical and operational differences between oral and long-acting buprenorphine
• Identify strategies to fund MOUD programs, including Opioid Abatement Authority grants
• Discuss regulatory and compliance considerations that influence MOUD implementation in jails

Level: Intermediate